Simpson Thacher advises Advanced Instruments on $2.2 billion acquisition of Nova Biomedical Corporation

Advanced Instruments is a global provider of scientific and analytical instruments serving the biotechnology, clinical, and food and beverage industries, and it is backed by Patricia Industries, part of Investor AB, whose main owner is the Wallenberg Foundations. The buyer is headquartered in Norwood, Massachusetts and has approximately 350 employees.
Advanced Instruments, a Patricia Industries portfolio company, agreed to acquire Nova Biomedical from its founding shareholders for an enterprise value of US$2.2 billion, with funding from a combination of external debt and equity provided by Patricia Industries.
Closing is expected in the third quarter of 2025, subject to regulatory approvals. The transaction will merge Advanced Instruments with Nova Biomedical.

Nova Biomedical Corporation sold the stake/assets to Advanced Instruments as part of a acquisition on 2025-03-19.
Deal value was 22000000000 (source: Extracted) Sector: Biotechnology; Location: USA.
Seller-side legal counsel was not specified.

Advanced Instruments is a global provider of scientific and analytical instruments serving the biotechnology, clinical, and food and beverage industries, and it is backed by Patricia Industries, part of Investor AB, whose main owner is the Wallenberg Foundations. The buyer is headquartered in Norwood, Massachusetts and has approximately 350 employees.
Advanced Instruments, a Patricia Industries portfolio company, agreed to acquire Nova Biomedical from its founding shareholders for an enterprise value of US$2.2 billion, with funding from a combination of external debt and equity provided by Patricia Industries.
Closing is expected in the third quarter of 2025, subject to regulatory approvals. The transaction will merge Advanced Instruments with Nova Biomedical.

Nova Biomedical Corporation sold the stake/assets to Advanced Instruments as part of a acquisition on 2025-03-19.
Deal value was 22000000000 (source: Extracted) Sector: Biotechnology; Location: USA.
Seller-side legal counsel was not specified.

Deal Overview